Recruiting Trials: Umbilical Cord Tissue

Você está aqui

This portal enables our readers to find registered clinical trials worldwide that are currently enrolling patients for therapies that employ Mesenchymal Stem/Stromal Cells (MSC) from umbilical cord tissue. If you are a patient seeking more information about a trial, please click on the link under the trial's registry identification. That will take you to the original trial registration, and within that description you should find contact information. This list does not constitute medical advice and Parent's Guide to Cord Blood Foundation has no relationship with any of these trial sponsors. We maintain this list by checking multiple national clinical trial registries. We only display clinical studies that are registered on an official trials registry. Complete through 30 April 2020.

This web page was researched by Frances Verter, PhD, Alexey Bersenev, MD PhD, and Pedro Silva Couto, MSc ©2016-2020. Sources of clinical trials were searches of ClinicalTrials.gov, Chinese Clinical Trial Registry (ChiCTR), Japan University hospital Medical Information Network Clinical Trial Registry (UMIN-CTR), Japan Medical Association Clinical Trial Registry (JMA-CTR), Clinical Research Information Service from South Korea (CRiS), EU Clinical Trials Register (EudraCT), World Health Organization International Clinical Trials Registry Platform (ICTRP), Netherlands Trial Register (NTR), Australian New Zealand Clinical Trial Registry (ANZCTR), Clinical Trials Registry-India (CTRI), German Clinical Trials Register (DRKS), and Iranian Registry of Clinical Trials (IRCT).

Visualização de ensaios clínicos em fase de recrutamento num total de 3 localizações.

Autism, or autism spectrum disorder, refers to a range of conditions characterized by challenges with social skills, speech, and repetitive behaviors. Autism is usually diagnosed between 2 and 3 years of age; as of 2021 autism impacts 1 in 44 children in the United States according to the CDC.Clinical trials have explored cell therapy for autism, using either cord blood or cord tissue. Some of the children that have benefited from cord blood therapy are Nicoloz, Levi, and Maksim. Therapy with cells from cord tissue have helped Gage.

Trial registry	Patient Ages	Hospital Name
IRCT20200217046526N3	36 to 60 mos	Roozbeh Hospital, Tehran, Iran
NCT04089579	4 to 7	Duke University Medical Center, United States
NCT04294290	18 to 30 mos	Duke University Medical Center, United States